Ei­sai finds an ex­it from Aduhelm, with small roy­al­ties if it ever nabs cov­er­age

With less than a month to go to the fi­nal na­tion­al cov­er­age de­ter­mi­na­tion from CMS, Bio­gen’s Japan­ese part­ner Ei­sai is es­sen­tial­ly cut­ting its loss­es on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER